Century Therapeutics Inc (IPSC) — Financial Flexibility Index
Century Therapeutics Inc (IPSC) has a Financial Flexibility Index of -0.35x as of June 2026. Free cash flow of $-19.27 Million (operating CF $-19.85 Million minus capex $584.00K) represents 0% of total liabilities ($54.66 Million). Check total reinvestment intensity of Century Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Century Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Century Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see IPSC operating cash flow.
Annual Financial Flexibility Index for Century Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Century Therapeutics Inc. Explore IPSC operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.59x | $-103.03 Million | $-103.88 Million | $64.77 Million | ▼ -177.5% |
| 2024 | -0.57x | $-109.98 Million | $-110.14 Million | $191.85 Million | ▼ -35.2% |
| 2023 | -0.42x | $-74.61 Million | $-88.35 Million | $175.94 Million | ▼ -274.6% |
| 2022 | 0.24x | $44.66 Million | $14.05 Million | $183.81 Million | ▲ +122.7% |
| 2021 | -1.07x | $-44.03 Million | $-89.00 Million | $41.14 Million | ▼ -625.7% |
| 2020 | -0.15x | $-31.44 Million | $-41.27 Million | $213.19 Million | ▼ -96.6% |
| 2019 | -0.08x | $-13.71 Million | $-16.17 Million | $182.75 Million | ▼ -127.2% |
| 2015 | 0.28x | $133.69 Million | $104.30 Million | $484.99 Million | — |